Millions of Cycles, Zero Solutions: The Hidden Flaws in Femtech Research
Many apps track high volumes of low quality data. For example, mood logs or self-reported symptoms may be inconsistent, unverified, or not linked to any diagnostic pathways.
Femtech companies often boast about having millions of logged menstrual cycles and the largest datasets in women’s health. Yet despite all of this data, many of the most urgent health concerns for women remain unaddressed. The problem is not the size of the dataset. The problem is what the industry chooses to study.
Data Quantity vs. Data Quality
Femtech apps frequently highlight how many data points they collect. Cycle dates, symptoms, moods, sexual activity, sleep patterns, and lifestyle habits are logged by users with the hope that this information will lead to better insights into their health.
However, large datasets do not guarantee clinical relevance. A dataset becomes powerful only when the information being collected is directly tied to health outcomes that matter. Many apps track high volumes of low quality data. For example, mood logs or self-reported symptoms may be inconsistent, unverified, or not linked to any diagnostic pathways.
As a result, companies often publish research that reveals correlations that are interesting from a statistical standpoint but irrelevant for people seeking answers about pain, fertility issues, or hormonal disorders. The presence of millions of cycles does not automatically translate into meaningful solutions.
Gap Analysis: The Conditions That Remain Invisible
Despite the rapid growth of femtech, several major health conditions continue to receive little attention. Endometriosis, PCOS, adenomyosis, perimenopause, and chronic pelvic pain remain difficult to diagnose and poorly understood. These conditions significantly impact quality of life, yet most femtech apps do not attempt to identify them or flag potential warning signs.
There is also a noticeable lack of work focused on cycle irregularities, persistent pain patterns, or fertility issues that require early detection. Instead of targeting these areas, many apps produce research on narrow or low impact topics that are easy to analyze with existing data.
The result is a widening gap between what women need and what the industry studies. The issues that disrupt daily life remain invisible in the very datasets that claim to represent women’s experiences.
Despite the rapid growth of femtech, several major health conditions continue to receive little attention.
Endometriosis, PCOS, adenomyosis, perimenopause, and chronic pelvic pain remain difficult to diagnose and poorly understood.
Industry Incentives: Why Easy Research Wins
The femtech industry is shaped by incentives that reward speed, novelty, and prestige. Studies that are simple to conduct, easy to publish, and low in regulatory risk are far more appealing to startups than rigorous clinical research.
Clinical studies require oversight, medical partnerships, and validation protocols. They involve real patients, long-term follow up, and a commitment to accuracy. These studies can take years and cost significant money.
In contrast, an app can analyze existing user data, generate a publishable correlation, and release a press announcement with far less effort. This type of research looks impressive, attracts media attention, and satisfies investors who want innovation at a fast pace.
Unfortunately, this incentive structure pushes the industry toward superficial science rather than impactful discovery.
Many believe that by sharing their information, they are contributing to research that will finally move women’s health forward.
When the resulting insights fail to address the issues they struggle with, it creates disappointment and distrust.
Emotional Angle: The Lived Experience Gap
Women who use these apps are not just logging data. They are documenting pain, confusion, irregular cycles, frustration, and hope. They are looking for clarity when their symptoms disrupt work, relationships, and daily routines.
Many believe that by sharing their information, they are contributing to research that will finally move women’s health forward. When the resulting insights fail to address the issues they struggle with, it creates disappointment and distrust.
There is a widening emotional gap between what women experience and what femtech delivers. Data is being collected, but the problems that matter most remain unsolved.
The Sheranked Approach: Evidence Based Evaluation
Sheranked focuses on evaluating femtech apps through a clinical and evidence based lens. Instead of being persuaded by large datasets or prestigious partnerships, we examine whether an app provides meaningful value for users.
Our framework asks clear questions that focus on real health outcomes:
Does the app help identify potential conditions?
Does it provide guidance that aligns with clinical standards?
Does it use data in a way that leads to better care or earlier intervention?
We prioritize tools that offer measurable benefits, not just aesthetic dashboards or publishable correlations.
Our reviews are designed to help users and clinicians understand which apps are genuinely useful and which ones fall short.